 adjuv chemotherapi long-term surviv patient advanc gastric cancer cur resect effect postop adjuv chemotherapi mitomycin mmc tegafur psk immunomodul patient advanc gastric cancer histolog cur resect effect chemotherapi prognost seros ps invas ps ps lymph node metastasi eighteen patient no-chemotherapi group drug median follow-up time survivor time analysi year regard prognost factor differ group wilcoxon test surviv pattern valu surviv rate year patient no-chemotherapi group chemotherapi group particular adjuv chemotherapi effect patient ps ps ps ps find concomit prescript mmc tegafur psk surviv rate patient advanc gastric cancer cur resect surviv rate low patient ps aggress postop chemotherapi